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a b s t r a c t
Talin binds to and activates integrins and is thought to couple them to cytoskeletal actin. However, func-
tional studies on talin have been restricted by the fact that most cells express two talin isoforms. Here
we show that human umbilical vein endothelial cells (HUVEC) express only talin1, and that talin1 knock-
down inhibited focal adhesion (FA) assembly preventing the cells frommaintaining a spreadmorphology,
a phenotype that was rescued by GFP-mouse talin1. Thus HUVEC offer an ideal model system inwhich to
conduct talin structure/function studies. Talin contains an N-terminal FERM domain (comprised of F1, F2
and F3 domains) and a C-terminal ﬂexible rod. The F3 FERMdomain binds-integrin tails, andmutations
in F3 that inhibited integrin binding (W359A) or activation (L325R) severely compromised the ability ofctin cytoskeleton GFP-talin1 to rescue the talin1 knockdown phenotype despite the presence of a second integrin-binding
site in the talin rod. The talin rod contains several actin-binding sites (ABS), and mutations in the C-
terminal ABS that reduced actin-binding impaired talin1 function, whereas those that increased binding
resulted in more stable FAs. The results show that both the N-terminal integrin and C-terminal actin-
binding functions of talin are essential to cell spreading and FA assembly. Finally, mutations that relieve
lted
the ctalin auto-inhibition resu
of talin regulation within
ntroduction
Integrin-mediated cell adhesion, spreading and migration
nvolve a complex interplay between the signalling pathways that
egulate the afﬁnity and avidity of integrins for extracellularmatrix
roteins, integrin recycling and the structure and dynamics of the
ctin andmicrotubule networks (Vicente-Manzanares et al., 2009).
he large adaptor protein talin plays a key role in this regard,
nd is part of the mechanism by which integrins are switched
rom the low to high afﬁnity state (Calderwood, 2004), and it also
rovides a physical link between integrins and F-actin (Critchley,
009). Talin was originally discovered as a component of cell-
atrix junctions (focal adhesions; FA) in cells in culture (Burridge
nd Connell, 1983), andmanipulation of talin function using a vari-
ty of approaches have conﬁrmed that it is required for both cell
Abbreviations: FA, focal adhesions; FB, ﬁbrillar adhesions; FERM, band 4.1, ezrin,
adixin,moesin; C-ABS, C-terminal actin-binding site;HUVEC, humanumbilical vein
ndothelial cells.
∗ Corresponding authors. Tel.: +44 116 229 7085; fax: +44 116 229 7018.
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Open access under CC BY license. in the rapid and excessive production of FA, highlighting the importance
ell.
© 2010 Elsevier GmbH. 
spreading and FA assembly (Albiges-Rizo et al., 1995; Nuckolls et
al., 1992; Priddle et al., 1998; Zhang et al., 2008).
Talin (270kDa, 2541 amino acids) is a member of the FERM
domain family of proteins, and substantial progress has beenmade
in establishing how it interacts with integrins, F-actin and the FA
protein vinculin (Critchley, 2009). The N-terminal talin head con-
tains a FERMdomain, and like other FERMdomains, it ismade up of
F1, F2 and F3 domains, although it is atypical in that the F1 domain
contains a large unstructured loop and is preceded by an addi-
tional domain F0. Interestingly, this domain organisation is very
similar to that of the kindlin family of FERM proteins (Goult et al.,
2009b) that synergise with talin to activate integrins (Moser et al.,
2009). Structural studies show that the talin F3 PTB-like domain
binds to both the membrane proximal NPxY motif and the heli-
cal region in -integrin tails (Anthis et al., 2009; Garcia-Alvarez
et al., 2003; Wegener et al., 2007), and mutations in F3 that dis-
rupt these interactions abolish the ability of the talin FERMdomain
Open access under CC BY license. to activate integrins. However, it has also become apparent that
basic regions in the F1 loop (Goult et al., 2010), F2 and F3 (Anthis
et al., 2009; Saltel et al., 2009; Wegener et al., 2007) that interact
with acidic phospholipids are also required for integrin activation
in vitro.
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The talin FERMdomain is linked through an apparently unstruc-
ured region to the large ∼2000 amino acids ﬂexible talin rod,
hich is made up of a series of 4- and 5-amphipathic helical bun-
les (Critchley, 2009). The rod contains a second integrin-binding
ite (IBS2) of unknown function (Gingras et al., 2009; Rodius et al.,
008), numerous vinculin-binding sites (Gingras et al., 2005) and at
east two actin-binding sites (Hemmings et al., 1996), the best char-
cterisedofwhich is at theC-terminus (C-ABS) (Gingras et al., 2008;
mith and McCann, 2007). It comprises a 5-helix bundle followed
y ahelix thatmediates talin dimer formation (Gingras et al., 2008),
nd only the dimeric C-ABS binds efﬁciently to F-actin. Finally, talin
s thought to exist in both an active open conformation and a more
ompact auto-inhibited form that is in part due to binding of the
3 FERM domain to a 5-helix bundle (residues 1655–1822) in the
alin rod (Goksoy et al., 2008; Goult et al., 2009a). Signiﬁcantly, this
nteractionmasks the integrin-binding site in F3, andboth the small
TPase Rap1 (Han et al., 2006; Lee et al., 2009) and PIP2 (Goksoy
t al., 2008; Martel et al., 2001) have been implicated in activating
alin.
Studies on talin in vertebrates at the cellular andorganismal lev-
ls are complicated by the existence of two talin genes that encode
imilar proteins (Debrand et al., 2009). Although the functional dif-
erences between the two isoforms have not been established, loss
f talin1 is embryonic lethal at gastrulation (Monkley et al., 2000)
hereas talin2 knockout mice are viable and fertile (Chen and Lo,
005). However, talin2 appears to compensate for loss of talin1 in
ells in culture, and ﬁbroblasts derived from Tln1−/− ES cells upreg-
late talin2, and are able to spread and assemble FA (Priddle et al.,
998; Zhang et al., 2008).We therefore sought to identify a cell type
hat was easy to grow and transfect, and in which we could knock-
ut or knockdown talin1 without upregulation of talin2. In the
resent study, we have shown that human umbilical vein endothe-
ial cells (HUVEC) fulﬁl these criteria. Thus HUVEC express only
alin1, and siRNA-mediated knockdown of human talin1 results in
reduction in cell spreading and FA assembly, a phenotype that
an be rescued by expression of mouse GFP-tagged talin1. This has
nabled us to conduct a comprehensive analysis of the function of
alin1 as it relates to the structure of the protein.
esults
nockout of talin1 in mouse ﬁbroblasts rapidly leads to
pregulation of talin2
To explore the relationship between talin1 structure and
unction, we initially sought to establish a talin1 null cell line. Con-
entional talin1 knockout mice die around 8.0dpc (Monkley et al.,
000) making it impossible to derive ﬁbroblasts from this source.
e therefore generated a mouse line carrying both conditional
alin1 and inducible CreER alleles. While treatment of ﬁbroblasts
erived from these mice with 4-hydroxy-tamoxifen could be used
o generate talin1 null cells, the system proved problematic in that
alin2 was rapidly upregulated (Fig. S1A), and the cells were still
ble to assemble paxillin-containing FAs (Fig. S1B). In addition, pri-
ary cultures were difﬁcult to transfect, possessed variable cell
orphologies both prior to and following loss of talin1 and dif-
ered in the timing of talin1 protein depletion following treatment
ith 4-hydroxy-tamoxifen (Fig. S1C).
uman umbilical vein endothelial cells (HUVEC) only express
alin1
Disruptionof the talin1gene inmouseembryosatmid-gestation
esults in extensive haemorrhage (Monkley et al., unpublished
ata), and this led us to wonder whether endothelial cellsCell Biology 89 (2010) 661–673
might only express talin1. Analysis of talin1 and talin2 expres-
sion in HUVEC using isoform-speciﬁc monoclonals showed that
as predicted, HUVEC only express talin1 whereas human fore-
skin ﬁbroblasts express both isoforms (Fig. 1A). Similarly, RT-PCR
showed that HUVEC contain little or no talin2 mRNA (Fig. 1A;
Fig. S2A), suggesting that the block in talin2 expression is at the
transcriptional level. Talin1 was localised to the relatively small FA
formed by HUVEC, and no signal was obtained for talin2 (Fig. 1B)
even in cells with higher passage numbers (data not shown).
Knockdown of talin1 in HUVEC leads to a loss of FAs and actin
stress ﬁbres
To investigate the role of talin1 in cell spreading and FA assem-
bly, HUVEC were transfected with talin1 siRNAs from Invitrogen,
and one was identiﬁed that was particularly effective in inducing
rapid knockdown of talin1 at the protein level. By 72h, no talin1
signal could be detected (Fig. 1C) although low levels of talin1
began to emerge after 120h (data not shown). In contrast, a univer-
sal negative control RNA (conRNA) had no effect on talin1 protein
levels. Knockdown of talin1 did not lead to a concomitant rise in
expression of talin2 (Fig. S2B). HUVEC were therefore transfected
with the talin1 siRNA or conRNA and 72h later were replated onto
glass coverslips for a further 24h after which the cells were ﬁxed
and stained for the FA marker paxillin. Subconﬂuent cells trans-
fectedwith the conRNAwerewell spread and contained numerous
paxillin-containing FAs, whereas cells transfected with the talin1
siRNA were elongated with few FAs (Fig. 1D and Fig. S2C). There
was also a complete loss of actin stress ﬁbres and an accumulation
of F-actin in lamellae,whereas in the controls, stress ﬁbres spanned
the whole cell and terminated in talin1-positive FA (Fig. 1E).
Effects of talin1 knockdown on cell spreading and migration
To investigate the effect of talin1 knockdown on the rate of
cell spreading, HUVEC were transfected with the talin1 siRNA or
conRNA, and 72h later, the cells were replated on tissue culture
plastic and imaged over a period of 14h. Initially, both control and
talin1 knockdown cells adhered and began to spread with sim-
ilar kinetics although the overall proportion of spread cells was
slightly reduced in the talin1 knockdown cells (Fig. 2A), and the
extent of cell spreading was more variable (Fig. S2D). Quantitative
analysis of spread cell area showed that after 15min there was no
signiﬁcant difference between controls and talin1 knockdown cells
(Fig. 2B; conRNA 273.5m2 ±36.3; talin1 siRNA 180.6m2 ±41.1;
p=0.1099).However, after2h, controlshadreachedanearmaximal
spread cell area of 1645.5m2 ±231.3while the talin1 knockdown
cells were markedly smaller (465.0m2 ±93.3, p=0.0001), a dif-
ference that was maintained for the entire 14h period (Fig. 2B). To
study the effects of talin1 knockdown on cell shape in more detail,
the morphology of each cell was assigned to one of four differ-
ent categories; “spread”, “arborized”, “elongated” and “not spread”
(see Materials and methods). Most conRNA-treated cells (∼78%)
were well spread 7h after replating, and only a small number
(∼8%) failed to spread. In contrast, although talin1 knockdown cells
spread initially (1h), over time theybecameelongatedor arborized,
and by 24h, only 40% of the cells were spread with 18% remaining
unspread (Fig. 2C).
Analysis of cell migration using the Manual Tracking plugin
and Chemotaxis tool for ImageJ showed that talin1 knockdown
cells showed reduced migration compared to controls (Fig. 2D
and E). They travel a signiﬁcantly shorter trajectory (accumulated
distance; p=0.002), and Euclidean distance (the shortest linear dis-
tance from the starting point to the end point; p=0.0001) with a
slightly reduced velocity (Fig. 2F). As a consequence, the index of
directionality deﬁned as the ratio of the Euclidean distance divided
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Fig. 1. siRNA knockdown of talin1 in HUVEC abolishes FA assembly.
(A) Leftpanel:Westernblotsof cell lysates fromhuman foreskinﬁbroblasts (hFF) and
HUVECprobedwithantibodies speciﬁc for talin1 (TA205)and talin2 (mAb121A(53)).
Anti-tubulin was used as a loading control. Right panel: RT-PCR ampliﬁcation of
mRNA from hFF or HUVEC (30 cycles) using primers speciﬁc for TLN1 (exons 33–34)
and TLN2 (exons 54–55). H2O, control. RT(+) reverse or RT(−) non-reverse tran-
scribed mRNA. (B) Confocal images of HUVEC stained with antibodies speciﬁc for
talin1 (97H6, left) and talin2 (68E7, right). Scale bar: 10m. (C) Western blot of
HUVEC treated with a talin1 or control siRNA (conRNA) for 24–96h; cell lysates
were probed with anti-talin1 (97H6), with anti-vinculin as a loading control. (D)
HUVEC treated with a talin1 siRNA or conRNA were replated onto glass coverslips
48h after transfection, and stained 24h later for paxillin. Scale bar: 10m. (E) Epi-
ﬂuorescence image of HUVEC treated as in (D) and stained for F-actinwith TexasRed
phalloidin (red) and for talin1 withmAb 97H6 (green). Scale bars: 10m (For inter-
pretation of the references to colour in this ﬁgure legend, the reader is referred to
the web version of the article).Cell Biology 89 (2010) 661–673 663
by the accumulated distance, is smaller compared to control cells
(Fig. 2F). Taken together these data suggest that talin1 is not needed
for adhesion of HUVEC or for initial cell spreading, but it is required
tomaintain the spreadphenotype, for persistenceof cellmovement
and for FA assembly.
Mouse GFP-talin1 rescues the talin1 knockdown phenotype
To conﬁrm that the knockdown phenotype could be rescued
by re-expressing talin1, HUVEC were transfected with the human
talin1 siRNA together with a plasmid encoding GFP-tagged mouse
talin1. After 72h, cells were replated on glass coverslips, and ana-
lysed a further 24h later. GFP-talin1 expression was conﬁrmed
by Western blotting (Fig. S3A). To ensure that phenotypic analy-
sis was conducted on cells expressing similar levels of GFP-talin1,
we only imaged those cells that could be visualised at exposure
times between 400 and 600ms on the epiﬂuorescencemicroscope.
Inspection of these images showed that GFP-mouse talin1 fully res-
cued the spreading defect in talin1 knockdown cells whereas GFP
alone was unable to do so (Fig. 3A). Thus, the proportion of GFP-
talin1 expressors that were spread (Fig. 3B and C) and the number
of paxillin-containing FA (Fig. 3D) was about the same as in cells
transfected with the conRNA and GFP. GFP-tagged talin1 localised
to peripheral FA as well as to more central ﬁbrillar adhesions (FB)
(Fig. 3A arrow), although a cytoplasmic pool of what may be auto-
inhibited talinwas located around the nucleus. Analysis of the time
course of cell spreading showed that talin1 knockdown cells were
able to adhere and to spread at least initially (Fig. 3B and C), but this
was not maintained, and after 1h the cells had started to adopt an
arborized morphology with multiple protrusions (Fig. 3B) which
ultimately resulted in a reduced spread cell area (Fig. 3C). Cells
rescued with wild-type GFP-talin1 showed a transient increase in
arborized cells (5–7h), but after 24h the majority of cells (69%)
were well spread. The talin1 knockdown phenotype could also be
rescued by GFP-talin2 (Fig. 3A–C) which localised to FA and FB
adhesions, although the size and number of paxillin-containing FA
was slightly less than in cells expressing GFP-talin1 (Fig. 3D and E).
Mutations in the F3-integrin-binding domain of talin1 inhibit cell
spreading and FA assembly
Talin1, and more speciﬁcally the talin1 FERM domain, has been
shown to play a central role in integrin activation (Nieswandt et
al., 2007; Petrich et al., 2007; Tadokoro et al., 2003; Wegener et al.,
2007) and clustering (Saltel et al., 2009), and a structural basis for
this effect has begun to emerge (Anthis et al., 2009; Garcia-Alvarez
et al., 2003; Wegener et al., 2007). We sought to evaluate the con-
clusions drawn from structural studies by testing the effects of two
F3mutations (R358AandW359A) that dramatically reducebinding
of a talin F2F3 polypeptide to the 739-WDTANNPLYDE-749 region
of3-integrin tails (Garcia-Alvarez et al., 2003). As predicted, a full-
length GFP-talin1 W359A mutant was unable to rescue the talin1
knockdown phenotype, although surprisingly, cells expressing the
GFP-talin1 R358A mutant adopted a near wild-type morphology
(Fig. 4B and C). After 24h, the spread cell area of GFP-talin1W359A
expressorswas signiﬁcantly (p=0.0001) reduced compared to cells
expressing wild-type talin1 (Fig. 4D). More detailed time course
studies showed that cells expressing theW359Amutant were able
to spread during the ﬁrst 3h (Fig. 4G and H and Fig. S3B), but
they failed tomaintain a spreadmorphology.Moreover, GFP-talin1
W359A failed to support FA assembly, and those FA that did form
were smaller and fewer in number than in control cells (Fig. 4B,
E and F). In contrast, the R358A mutant localised efﬁciently to FA
(Fig. 4B), and the FA were comparable in number and size to those
in controls (Fig. 4E and F). Despite this, the spread cell area of the
GFP-talin1 R358A expressors was substantially reduced compared
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Fig. 2. Effects of talin1 knockdown on cell spreading. HUVEC transfected with either the talin1 siRNA or conRNA were replated 72h after transfection on tissue culture
plastic, and imaged every 15min for the times indicated. (A) The percentage of spread cells was recorded from 3 experiments; mean± s.e.m. (B) The areas of 12 cells each
from two experiments weremeasured using ImageJ. Results are expressed as mean± s.e.m. (C) Quantitative analysis of cell morphology at various time points after replating
(expressed as mean± s.e.m.) using the criteria described in Methods. “Spread cell” (white ﬁlled arrow in D). “Arborized” (white empty arrow in D). “Elongated” (black ﬁlled
arrow in D). “Not spread” (black empty arrow in D). n=300 for each time point/sample. (D) HUVEC were imaged every 15min for 18h, and three representative cells tracked
using the manual tracker tool plugin for ImageJ. Scale bar, 10m. (E) Migration plots of HUVEC as in (D). For each plot 25 cells were tracked using the Manual Tracker and
Chemotaxis Tool plugins for ImageJ. (F) Quantitation of migration parameters from (E) expressed as mean± s.e.m. Asterisks represent a signiﬁcant difference between the
two groups. p-values are shown under each graph.
P.M. Kopp et al. / European Journal of
Fig. 3. GFP-talin1 or talin2 rescues cell spreading and FA formation in talin1-
depleted HUVEC. Cells were transfected with a talin1 siRNA or conRNA plus
constructs encoding either GFP alone, mouse talin1-GFP or human talin2-GFP. Cells
were replated on glass coverslips 72h after transfection. (A) Epiﬂuorescence images
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showing GFP localisation in cells 24h after replating. (B, C) Time course of changes
n cell morphology (B) and cell area (C). (D, E) FA number (D) and size (E) in different
ell populations quantiﬁed using ImageJ. All results are expressed as mean± s.e.m.
cale bars: 10m.
o wild-type (Fig. 4D) indicating that this mutation does have an
mpact on cell spreading.
Leucine 325 is part of a hydrophobic pocket in F3 that inter-
cts with the membrane proximal helical region of 3-integrin
ails (Fig. 4A), and a L325R mutation abolishes this interaction and
nhibits integrin activation (Wegener et al., 2007). Consistent with
he above ﬁndings, GFP-talin1 L325R was unable to support cell
preading (Fig. 4B and C), and the cell area was markedly reducedCell Biology 89 (2010) 661–673 665
(Fig. 4D). Time course experiments showed that aswith theW359A
mutation, GFP-talin1 L325R was able to support initial cell spread-
ing (1–3h), but after that the majority of cells became arborized
(Fig. 4G and H and S3B). Similarly, the number and size of FA was
dramatically reduced (Fig. 4E and F), and the GFP-talin1 L325R
mutant did not localise to FA (Fig. 4B), but instead accumulated in
lamellae that were highly dynamic (Fig. S4A). Together, the results
show that binding of talin F3 to the NPxYmotif and the membrane
proximal helix are both required to support cell spreading and FA
assembly. The fact that mutations in F3 that compromise integrin
binding or activation have such a marked effect on talin1 function
raises questions about the signiﬁcance of the integrin-binding site
in the talin rod (Moes et al., 2007; Rodius et al., 2008). Unfortu-
nately, although the structure of the domain containing this site
has been determined (Gingras et al., 2009), it has not proved pos-
sible to deﬁne the binding interface using structural methods, and
the role of this site therefore remains unresolved.
Effect of mutations in the C-ABS of talin1
To investigate the importance of the C-ABS in talin, we analysed
the ability of two GFP-talin1 mutants to rescue the talin1 knock-
downphenotype. Arginine2510 is on the exposedhighly conserved
face of the dimerisation helix (Fig. 5A) and makes salt bridges to
neighbouring residues. A C-ABS polypeptide (residues 2294–2541)
containing an R2510Amutation is still dimeric, but shows reduced
F-actin-binding (∼77% compared to wild-type) (Gingras et al.,
2008). Expression of GFP-talin1 R2510Apartially rescued the talin1
knockdown phenotype in HUVEC (Fig. 5B) although it was signif-
icantly less effective than wild-type GFP-talin1. Thus, there was
a small reduction in the percentage of spread cells (Fig. 5C), the
spread cell area was signiﬁcantly reduced (p=0.004, Fig. 5D), and
there were fewer FA per cell (Fig. 5E), although FA size was similar
to controls (Fig. 5F).
The ability of the C-ABS to bind actin is negatively regulated
by helix1 (Smith and McCann, 2007) which is anchored to the rest
of the domain through hydrophobic interactions (Fig. 5A), and a
L2309A/L2323A double mutant showed a considerable increase
(∼154%) in actin-binding compared to wild-type (Gingras et al.,
2008). Expression of GFP-talin1 L2309A/L2323A efﬁciently rescued
the talin1 knockdown phenotype as far as cellmorphology (Fig. 5B)
and the kinetics of cell spreading were concerned (Fig. 5H). How-
ever, the cells contained signiﬁcantly more (Fig. 5E) and slightly
larger FA (Fig. 5F), and confocal time-lapse microscopy and FRAP
analysis showed that GFP-talin1 L2309A/L2323A positive FA were
more stable (Fig. 5I and Fig. S4A), with a lower mobile fraction, and
an increased half-life. In summary, the results show that the C-ABS
plays an important role in talin1 function despite the presence of
several other ABSs in both the talin rod (Hemmings et al., 1996) and
the talin head (Lee et al., 2004).
Mutations that relieve talin auto-inhibition lead to accelerated FA
assembly
Talin can adopt an auto-inhibited conformation due to an inter-
action between the N-terminal F3 FERM domain and a C-terminal
domain in the talin rod (residues 1655–1822) that masks the
integrin-binding site in F3 (Goksoy et al., 2008; Goult et al., 2009a)
(Fig. 6B). We have identiﬁed several mutations in the talin rod that
abolish this interaction (Goult et al., 2009a), andwe therefore stud-
ied the effects of two of these mutations on cell spreading and FA
formation. HUVEC transfected with the talin1 siRNA and express-
ing either GFP-talin1 T1676E or GFP-talin1 E1770A were well
spread (Fig. 6A) although theT1676Emutationprovokeda transient
increase in the number of arborized cells at 5h (Fig. 6C). However,
the most striking effect of these mutations was the increased rate
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Fig. 4. Mutations in the talin1 FERMdomain affect cell spreading. HUVECwere transfectedwith a talin1 siRNAor conRNAplus constructs encoding either GFP alone,wild-type
GFP-talin1 (wt) or GFP-talin1 containing point mutations in the FERM domain. Cells were replated on glass coverslips 72h post transfection and imaged or ﬁxed/stained 24h
later. (A) Structure of the F3 domain of talin1 (green) complexed with the cytoplasmic tail of 3-integrin (red). Side chains of key residues are shown. (B) Epiﬂuorescence
images showing GFP localisation 24h after plating. (C) Cell morphology quantiﬁed at 24h after replating. (D–F) Cell area (D), and the number (E) and size (F) of FA quantiﬁed
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f FA formation, with the ﬁrst FA appearing as early as 30min after
eplating, while in cells transfected with wild-type GFP-talin1, the
rst FA were only observed after 1h (Fig. 6E and F). The number of
A continued to increase, and after 24h therewere 3 timesmore FA
n cells expressing either the T1676E or the E1770Amutant than in
ontrols (Fig. 6E and F), although FA sizewas not affected (Fig. S4B).
oth these GFP-talin1mutants localised to peripheral FA as well as
B-like adhesions (Fig. 6A arrows) whereas wild-type GFP-talin1
as predominantly localised in FA. The results indicate that path-
ays that regulate the talin head/rod interaction must play a key
ole in controlling the rate and extent of FA assembly.iscussion
Analysis of talin function using constitutive or conditional talin1
nockout cells has been severely limited by the rapid upregu-cell morphology or (H) cell area. All results are expressed as mean± s.e.m. p-values
A; p=0.003 (R358A); p=0..0001 (W359A & L325R). FA size; ns (R358A); p=0.001
ur in this ﬁgure legend, the reader is referred to the web version of the article).
lation of talin2, which appears to compensate for loss of talin1.
Therefore, the discovery that HUVEC only express talin1 mRNA
and protein, and that siRNA depletion of talin1 does not lead to
upregulation of talin2 represents a signiﬁcant breakthrough.More-
over, talin1 knockdown resulted in a robust cellular response i.e.
reduced cell spreading and FA assembly, a phenotype that was
rescued by the expression of mouse GFP-talin1. The major talin2
promoter is embedded in a CpG island (Debrand et al., 2009), and
we presume that the promoter is silenced in endothelial cells by
methylation. Indeed, it seems that other cells of the haematopoi-
etic lineage such as platelets (Nieswandt et al., 2007; Petrich et
al., 2007), megakaryocytes (Wang et al., 2008), and dendritic cells
(Lammermann et al., 2008) also only express talin1 whereas most
other cell types express both talin isoforms. However, the role of
each of the two isoforms is unclear. While expression of talin2 res-
cues the talin1 knockdown phenotype in HUVEC, talin1 null mouse
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Fig. 5. Mutations in the talin1 C-ABS affect cell spreading and FA assembly. HUVEC were transfected with a talin1 siRNA plus constructs encoding either wild-type or
GFP-talin1 with point mutations in the C-ABS. Cells were replated on glass coverslips 72h post transfection, and imaged then ﬁxed/stained 24h later. (A) Schematic diagram
of the dimeric C-ABS of talin1 showing the 5-helix bundle (THATCH domain), the dimerisation domain, and the actin-binding surface. Residues mutated are indicated. (B)
Epiﬂuorescence images showing localisation of the various GFP-talin1 constructs 24h after replating. (C, D) Cell spreading was quantiﬁed 24h after replating onto glass
coverslips and was based on cell morphology (C) or cell area (D). (E, F) Quantiﬁcation of FA size (E) and number (F). (G–H) Time course of cell spreading based on cell
morphology (G) or cell area (H). (I) FRAP analysis of FAs in cells expressing either wild-type GFP-talin1 or a GFP-talin1 L2309A/L2323A mutant. Left panel shows averaged
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o the bleached region of FA. Bar charts represent the mobile fraction (middle) a
ean± s.e.m. p-values compared to wt at 24h: Cell area; p=0.004 (R2510A). Num
L; mobile fraction p=0.0001, t1/2 p=0.07. Scale bars: 10m.
mbryos die at gastrulation (Monkley et al., 2000) even though
T-PCR-data (Debrand et al., 2009) and Western blotting show
hat talin2 is expressed in mouse ES cells. In contrast, talin1 and
alin2 clearly have overlapping functions in skeletal muscle, and
nockout of either gene alone gives rise to only a mild dystrophic
henotype, whereas knockout of both genes leads to a block inlls) with regression analysis to illustrate the rate of recovery of GFP-tagged talin1
lf-life (right) of the GFP-tagged constructs in the FA. All results are expressed as
FA; p=0.0001 (R2510A); p=0.001 (LL). FA size; ns (R2510A); p=0.0004 (LL); FRAP
myogenesis and is perinatal lethal (Conti et al., 2008, 2009). Inter-
estingly, talin2 co-localises with the muscle-speciﬁc 1D integrin
splice variant in myotendinous junctions (Conti et al., 2009), and
the talin2 F3 FERMdomain binds1D tailswith signiﬁcantly higher
afﬁnity than the talin1 F3 domain (Anthis et al., 2009). This may
stabilise the junction against the substantial forces exerted on it
668 P.M. Kopp et al. / European Journal of Cell Biology 89 (2010) 661–673
Fig. 6. Mutations that relieve talin1 auto-inhibition lead to the rapid assembly of FA. HUVEC were transfected with a talin1 siRNA plus constructs encoding either wild-type
GFP-talin1 (wt) or GFP-talin1 rod domain mutants (T1676E or E1770A) that disrupt talin auto-inhibition. Cells were replated on glass coverslips 72h post transfection, and
imaged then ﬁxed/stained 24h later. (A) Epiﬂuorescence images showing GFP-talin1 localisation 24h after plating. (B) Diagram of the intramolecular interaction between
the F3 FERM domain (green) and residues 1655–1822 in the talin rod (blue). (C, D) Time course of cell spreading following replating onto glass coverslips based on cell
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For interpretation of the references to colour in this ﬁgure legend, the reader is ref
uring muscle contraction, a hypothesis supported by the ﬁnd-
ng thatmuscle-speciﬁc talin2 knockoutmice develop a dystrophic
henotype earlier than talin1 knockout mice (Conti et al., 2008,
009). In brain, talin2 is the predominant isoform (Debrand et al.,
009), but although it is enriched innervegrowthcones (Pertz et al.,
008), talin2 gene trap mice (Chen and Lo, 2005) and those with a
omplete disruption of the talin2 gene (Debrand et al., unpublished
ata) are viable and fertile.
The ﬁnding that talin1-depleted HUVEC can initiate cell spread-
ngonplastic or glass surfaces in thepresenceof serum is consistent
ith the report that talin-depleted cells can initiate spreading on
bronectin but that this spreading cannot be maintained in the
bsence of talin (Zhang et al., 2008). The authors showed that talin
as not required for the Src family kinase (SFK) signalling events
hat initiate actin polymerisation and early edge protrusion, but
alin was essential for 1-integrin activation, FAK signalling, FA
ssembly and the exertion of force on the substrate. In the absence
f talin, the rate of myosin II-driven rearward ﬂow of actin was
arkedlyelevatedandprobably contributed to theeventual round-
ng up of the cells. The cellular response to talin1-depletion ines of cells 30min after replating showing localisation of the GFP-talin1 constructs.
.4 (T1767E, E1770A). Number of FA; p=0.0001 (T1767E, E1770A). Scale bars: 10m
to the web version of the article).
HUVEC was less severe andmany of the cells adopted an arborized
or elongated morphology, although there was a dramatic reduc-
tion in spread cell area as well as the number of FA and actin stress
ﬁbres. Cell spreading mediated by 3-integrin has been shown to
be dependent on binding of SFK to 3-tails but not on talin binding
(Arias-Salgado et al., 2005). Since themajor integrin in FA inHUVEC
is V3 (Jones et al., 2009), our results suggest that cell spreading
in talin1-depleted HUVEC is supported by “outside-in-signalling”
via the 3-integrin/SFK pathway.
We have exploited the fact that mouse GFP-talin1 can be used
to rescue the talin1 knockdown phenotype in subconﬂuent HUVEC
to carry out a comprehensive structure function study on talin1
in a cellular context (Fig. 7A). We started by testing the effects of
threemutations in the talin F3 FERMdomain that have been shown
to compromise integrin binding or activation (Garcia-Alvarez et al.,
2003;Wegeneret al., 2007). Previousanalysisof suchmutationshas
largely been restricted to monitoring effects on integrin activation,
and not cellular responses such as cell spreading or FA assembly.
Surprisingly, expression of the GFP-talin1 R358A mutant largely
rescued the talin1 knockdown phenotype in HUVEC, and the same
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Aig. 7. Interactions between talin and its binding partners in FA. (A)Mutations analy
n the N-terminal talin1 F1, F2 and F3 FERM domains are shown interacting with
omain is linked to the rod by a ﬂexible linker. The C-ABS is shown bound to a sing
ctivation are indicated.
utant has recently been shown to support Mn2+-induced V3-
ntegrin clustering in B16 melanoma cells (Saltel et al., 2009), and
ntegrin clustering in muscle (Tanentzapf and Brown, 2006). The
tructure of F3 bound to the 3-integrin tail shows that R358 is
art of a pocket that accommodates W739 of the 3-tail (Garcia-
lvarez et al., 2003). The guanadinium group of Arg358, which
tacks parallel to the aromatic ring of W739 in the 3-tail, points
nto solution, and it is likely that its loss would not perturb the
est of the pocket or the structure of the F3 domain. Therefore,
lthough the R358A mutation totally ablated binding of a 3-
ail peptide to F2F3 in vitro, it is likely that in the context of
ull-length talin expressed in the cell, other interactions between
he talin head, integrin tails and acidic membrane phospholipids
Goult et al., 2010; Anthis et al., 2009; Saltel et al., 2009) partially
ompensate for the effect of the R358A mutation on integrin bind-
ng.
In contrast, the GFP-talin1 W359A or L325R mutants markedly
ffected the ability of talin to rescue the knockdown phenotype.
359 plays a mainly structural role in F3 maintaining the packing
etween the 5 strand and the C-terminal helix (Garcia-Alvarez et
l., 2003), and the W359A mutation might well affect local fold-
ng. In addition, W359 and I396 form a hydrophobic surface that
nteracts with residues 740-DTA-742 of the 3-tail. Surprisingly, a
alin F2F3 W359A mutant retained some ability to bind 3-tails
hereas the R358A mutation totally abolished binding (Garcia-
lvarez et al., 2003). Therefore, the marked effect of the W359Athis studymapped on to the domain structure of talin. (B) Clusters of basic residues
membrane phospholipids whilst the F3 domain binds -integrin tails. The FERM
in ﬁlament. The auto-inhibited form of talin1 is also shown and possible modes of
mutation on the activity of full-length talin1 suggests that it likely
affects the conformation of the talin head such that other interac-
tions required for integrin activation are no longer possible. The
discrepancy between the effects of the R358A and W359A muta-
tions on integrin-binding in vitro versus their effects in the cell
illustrates the importanceof analysing theeffects of suchmutations
in a biological setting.
L325 is the ﬁrst residue in -strand 2 in the F3 FERM domain,
andwith theﬂexible loopbetween strands S1 andS2 (Fig. 4A) forms
part of a hydrophobic pocket that interacts with F727 and F730 in
the membrane proximal helix of 3-integrin tails (Wegener et al.,
2007). A L325R mutation abolishes the ability of the talin head to
activate integrins, although it does not affect binding of F3 to the
membrane proximal NPxY motif in vitro, which provides much of
the binding energy for the interaction (Wegener et al., 2007). In line
with the above data, the GFP-talin1 L325R mutant was unable to
rescue the phenotype of talin1-depletedHUVEC. Indeed, the effects
of the mutation on cell area and FA number and size were even
more pronounced than seen with the W359A mutant. The result
shows that binding of the talin F3 domain to -integrin tails on
its own is insufﬁcient to support integrin-mediated events, and
that engagement of F3 with the membrane proximal helical region
of -tails is essential to elicit a full biological response. However,
it is also apparent that other regions of the talin head are also
required for both 1- and 3-integrin activation (Bouaouina et al.,
2008), and we have recently identiﬁed clusters of basic residues
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n both the F1 loop (Goult et al., 2010) and on F2 (Anthis et al.,
009) that bind acidic phospholipids and are required for inte-
rin activation, but not binding. Lysine 322 in F3 has also been
hown to play a role in integrin activation (Wegener et al., 2007).
imilarly, basic residues on both F2 and F3 have recently been
hown to bind PIP2 and are required for talin head-mediatedMn2+-
ependent v3-integrin clustering (Saltel et al., 2009). Wegener
nd colleagues proposed that the interaction of basic residues on
oth F2 and F3 with acidic membrane phospholipids contributes
o the energy required to stabilise activated integrins (Wegener
t al., 2007), and the recent crystal structure of 1D integrin tails
omplexed to the F2F3 domains of talin2 (Anthis et al., 2009), and
he studies of studies of Saltel et al. (2009) are consistent with this
dea.
Experimentswith talin-depletedcells showthat talin is required
o couple integrins to the force generating actomyosin contractile
achinery (Jiang et al., 2003; Zhang et al., 2008). The best-
haracterised actin-binding site in talin is at theC-terminus (C-ABS)
Gingras et al., 2008; Smith and McCann, 2007), but its role in
ntegrin-mediated cell spreading and FA assembly has not been
nvestigated in any detail. Indeed, the observation that the cen-
ripetal translocation of integrin/talin complexes with F-actin is
inculin dependent led to the suggestion that it is the actin-binding
ite in the vinculin tail that provides the major link between
alin and the actomyosin contractile machinery (Humphries et al.,
007). Here we show that a R2510A mutation in the C-terminal
imerisation helix of C-ABS that reduces its afﬁnity for F-actin
y ∼40% (Gingras et al., 2008) compromises the ability of GFP-
alin1 to rescue the talin1 knockdown phenotype. Conversely, a
2309A/L2323Amutation that relieves inhibition of C-ABS by helix
causes a small but signiﬁcant increase in the number of FA.More-
ver, FRAP experiments show that thismutant exchanges from FAs
igniﬁcantlymore slowly than thewild-type GFP-talin1, indicating
hat it ismore tightly associatedwith FA.Howthe effect of helix1on
he C-ABS is regulated is not fully understood although recentwork
uggests that theremay be a functional link between the C-ABS and
BS2, the integrin-binding site located in the talin rod (Himmel et
l., 2009). It is also possible that force applied to integrin/talin/actin
omplexes by actomyosin contraction activates theC-ABSbyweak-
ning the interaction of helix1 with the 5-helix bundle, as for the
BSs in talin (del Rio et al., 2009) supporting the concept of talin
s a mechanotransducer (Roca-Cusachs et al., 2009). In addition, it
ay be relevant that S2338 in helix1 is phosphorylated in platelet
alin (Ratnikov et al., 2005).Whatever themechanism(s) our results
emonstrate that the talin1 C-ABS plays an important role in talin
unction, although vinculin bound to talin also has the potential to
ontribute to the interaction between integrin/talin complexes and
-actin.
The results of these and other studies are consistent with a
odel (Fig. 7B) in which basic residues on the F1, F2 and F3 FERM
omains interact with acidic phospholipids while the F3 domain
inds to -integrin tails and activates integrins in the process. The
-ABS plays a key role in coupling talin to the actin cytoskeleton,
ut since E.M. studies show that it binds along a single actin ﬁla-
ent, it cannot account for the ability of talin to cross-link F-actin
Gingras et al., 2008). Perhaps the other ABS in the talin head (Lee
t al., 2004) and rod (Hemmings et al., 1996) are important in this
egard. The ∼80 residues that link the talin FERM domain to the
od are unstructured and are therefore probably ﬂexible so that
he angle between the head and rod is likely to vary. Since talin is
bout 60nm long (Molony et al., 1987;Winkler et al., 1997) the dis-
ance between the head and the C-ABS could be of the same order.
owever, residues 1974–2293 contain a second integrin-binding
ite that also binds acidic phospholipids (Gingras et al., 2009), and
e do not exclude the possibility that the whole talin molecule
ould lie along the membrane.Cell Biology 89 (2010) 661–673
Talin exists inbothanactive extendedandamore compact auto-
inhibited form. Initial indications that this might be the case came
from E.M. (Molony et al., 1987; Winkler et al., 1997), and recent
NMR studies have shown that the talin F3 FERM domain binds to a
5-helix bundle (residues 1655–1822) in the talin rod masking the
integrin-binding site in F3 in the process (Goksoy et al., 2008; Goult
et al., 2009a). Although additional intramolecular interactionsmay
contribute to talin auto-inhibition, it is notable that GFP-talin1 con-
structs carryingmutations (T1767E or E1770A) in the talin rod that
abolish F3 binding led to a signiﬁcant (p=0.0001) increase in the
rate of FA assembly and the number of FA compared to controls.
The fact that the cells spread more slowly than controls may be
due to the overproduction of FA. Interestingly, the talin rod binds
to the same loop in F3 that is involved in integrin activation, and
mutations in basic residues in the loop that interact with a acidic
residues in the talin rod 5-helix bundle (Fig. 7B) enhance the ability
of full-length talin to promote Mn2+-induced V3-integrin clus-
tering (Saltel et al., 2009). Together, the results suggest that the
interaction of F3 with the 5-helix bundle in the talin rod (residues
1655–1822) is a major determinant of the auto-inhibited form of
themolecule, and that regulation of this interaction is likely to play
an important role in integrin-mediated FA assembly and cellmigra-
tion (Fig. 7B). Recent studies have shown that the small GTPase
Rap1 and its effector RIAM are key regulators of talin activation
(Han et al., 2006; Lee et al., 2009; Watanabe et al., 2008), and
it will be important to establish how RIAM exerts its effects on
talin. In addition, PIP-kinase type1 (Di Paolo et al., 2002; Ling et
al., 2002) and its product PIP2 (Goksoy et al., 2008; Martel et al.,
2001) have also been implicated in talin activation. PIP2 inhibits
the interaction between F3 and the talin rod (Goksoy et al., 2008),
and it has been proposed that PIP2 binds to basic residues in the
integrin activation loop disrupting the interaction with the talin
rod (Saltel et al., 2009). The relative contributions of these two
pathways to talin and integrin activation remain to be investi-
gated.
Material and methods
GFP-expression constructs, cell culture and transfection
Mouse talin1 cDNAs and human talin2 cDNAwere ampliﬁed by
PCR and cloned into either pEGFP-N1 (Clontech) or mCherry-N1
(a kind gift from Roger Y. Tsien). Point mutations were intro-
duced by site-directed PCRmutagenesis and authenticated by DNA
sequencing. All DNA used for transfection experiments was puri-
ﬁed using the Endofree MidiPrep Kit (Qiagen). Human umbilical
vein endothelial cells (HUVEC) were purchased from PromoCell at
passage 2 and grown according to the manufacturer’s instructions
in Endothelial Cell Growth Medium 2 (PromoCell) at 37 ◦C in 10%
CO2 and cultured on uncoated plastic dishes (VWR International).
siRNA-mediated knockdown of talin1
For siRNA knockdown of human talin1, three Stealth Select
RNAiTM (Invitrogen cat #1299003) were tested, and oligo 804 (seq:
CCAAGAACGGAAACCUGCCAGAGUU) was used for all subsequent
experiments. A Universal Stealth RNATM siRNA was used as a neg-
ative control (conRNA). Subconﬂuent HUVEC were trypsinized,
washed in PBS, and electroporated (6×106 cells/ml) using aMicro-
porator (Invitrogen) according to the manufacturer’s instructions,
with 100pmol of talin1 siRNA or controlRNA. Transfection efﬁ-
ciency was ∼98% as determined using ﬂuorescently labelled
siRNAs. Cells were grown on tissue culture plastic for 72h, and
replated at adensity of 4×104 cells on16mmglass coverslips (Ray-
mond A. Lamb) for analysis after a further 24h.Where appropriate,
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ellswere co-transfectedwith 0.5g of plasmidDNA encodingGFP
r wild-type/mutant GFP-talin1.
NA extraction and RT-PCR
Total cellular RNA was extracted using the RNAeasy Miniprep
it (Qiagen) according to themanufacturer’s instructions. RNAcon-
entrationswere quantiﬁed at 260/280nmand treated accordingly
ith Turbo DNase (Ambion). DNase treated total RNA (1g) was
everse transcribed with Superscript III (Invitrogen) and 500ng
f random primers (Promega) in a total volume of 40l as rec-
mmended by Invitrogen. In addition, non-reversed transcribed
ontrols were generated under the same conditions by replacing
he Superscript III enzyme with water. TLN1 primer pairs from
ttp://primerdepot.nci.nih/gov: left primer sequence (exon 33) 5′-
CTCCCAAAATGCCAAGAAC-3′, right primer sequence (exon 34)
′-TGGCTATTGGGGTCAGAGAC-3′ were used. For TLN2 the follow-
ng primers were designed to detect all TLN2 transcript isoforms:
eft primer sequence 5′-CTGAGGCTCTTTTCACAGCA-3′, (exon 54)
nd right primer sequence 5′-CTCATCTCATCTGCCAAGCA-3′ (exon
5). GAPDH primers were as described in Debrand et al. (2009).
mpliﬁcation was performed in standard conditions at an anneal-
ng temperature of 60 ◦C using primers at 600nM and PCR Reddy
ix (ThermoScientiﬁc) in a volumeof 15l. Expression of TLN1 and
LN2 mRNAs was quantiﬁed using real-time PCR in a Roche Light-
ycler with SybrGreen Mix (Fermentas) and the speciﬁc primer
ets described above. Primers were used at a ﬁnal concentration
f 300nM in a 25l reaction volume. One microlitre of random-
rimed cDNA was added to each reaction, and each cDNA sample
as ampliﬁed in triplicate. The absolute quantity of cDNA in each
amplewas interpolated on a standard curve obtained from a serial
ilution of human foreskin ﬁbroblast (hFF) cDNA. GAPDH was used
s an internal normalization control.
estern blotting
Cells were lysed in Laemmli buffer, proteins were resolved by
DS-PAGE and blotted to PVDFmembranes The following isoform-
peciﬁc talin monoclonal antibodies were generated during the
ourse of this study andwill be described inmore detail elsewhere:
nti-talin1 97H6, anti-talin2 68E7 and 121A(53). A previously
haracterised anti-talin1 monoclonal, TA205 (Bolton et al., 1997)
rom Santa Cruz was also used. Other antibodies used were: anti-
inculin F9 (Santa Cruz), anti-paxillin (BD Transduction), anti-actin
Sigma) and anti-alpha-tubulin (Abcam). HRP-coupled anti-mouse
nd anti-rabbit were from GE Healthcare.
mmunoﬂuorescence and microscopy
Transfected HUVEC were cultured for 24h on glass coverslips,
xed in 3.5% formaldehyde in PBS-ME (containing 3mMMgCl2 and
mM EGTA) for 10min at room temperature, permeabilized with
.2% Triton X-100 in PBS-ME for 5min and stained for F-actin with
lexa 647-phalloidin (1:200) or anti-paxillin (Sigma, 1:100). Talin1
nd talin2 were visualised with monoclonal antibodies 97H6 and
8E7, respectively. In this case, and for visualising F-actin with an
nti-actin antibody (Sigma, 1:150), cells were ﬁxed and permeabi-
ized in one step with ice-cold methanol for 1min. Cells were then
ncubated with 2.5% normal goat serum and 2.5% normal mouse
erum for 15min before staining in 1% BSA in PBS-ME. Alexa-488 or
lexa-594 coupled secondary antibodies (Molecular Probes) were
sed at a dilution of 1:200. Epiﬂuorescence images were taken
ith a 40x oil immersion objective on an inverted Nikon TE300
icroscope equipped with a Hamamatsu ORCA-ER digital camera
nd an X-cite 120 ﬂuorescence illumination system controlled by
mprovision’s Openlab software. For time-lapse experiments, theCell Biology 89 (2010) 661–673 671
temperature was kept at 37 ◦C in an atmosphere containing ∼5%
CO2. For confocal laser-scanning microscopy, either a Leica TCS
SP5 system consisting of a Leica DMI-6000 CS inverted microscope
or an Olympus FV1000 system with an inverted IX81 motor-
ized microscope was used with the following emission settings:
500–550nm for 488nm excitation (for GFP and FITC), 570–650nm
for 561nmexcitation (TexasRed andmCherry) and 660–755nm for
633nmexcitation (Alexa647). For time-lapse experiments the cells
were plated on 35mm -slides (ibidi GmbH) and phenol-red-free
Endothelial Cell Growth Medium 2 (PromoCell) was used.
FRAP analysis
Experiments were performed using a Leica TCS SP5 system
attached to a Leica DMI-6000 CS inverted microscope equipped
with a 63× oil immersion objective (NA 1.4). Stage and objective
were placed in an environment chamber pre-equilibrated to 37 ◦C.
The cells were kept at 5% CO2 on the stage. The image acquisition
was performed using the Leica FRAP Wizard using bidirectional
scanning at 400Hz in an image format of 1024×1024 pixel. The
bleaching set up consisted of a pre-bleach period of 5 frames at 5%
laser power at 488nm, then an area of 2m×2m was bleached
with a laser intensity of 70% for 5 frames, followed by a post-bleach
period for 40 frames at 5% laser intensity. The emission settings
were 500–550nm and a 6× zoomwas used. Time interval between
the start of each image during pre- and post-bleaching was 3 s.
Background values were determined and subtracted from all raw
data before further analysis withMS Excel. Themobile fractionwas
calculated as themaximum intensity of recovery after curve ﬁtting,
and the t1/2 as the period of time elapsed until the curve reached
half its maximum.
Image and data analysis
Imageswere analysed using ImageJ (NIH) by converting them to
8-bit images. Following thresholding, cell area, FA/FB number and
size were measured by setting the size limits of the measured par-
ticles to 20–500 pixels (0.3–70m2). For each experiment 30 cells
were analysed, and the experiment was conducted in triplicate.
Cell morphology was assessed on 100 cells/experiment and exper-
iments were conducted in triplicate. The following criteria were
used: “spread”: area of cytoplasm is three times bigger than the
area of the nucleus; “arborized”: cell with more than 5 prominent
protrusions or more than 3 axes, “elongated”: cell width at least 5
times bigger than cell length, “not spread”: area of cytoplasm is as
big or smaller than three times the area of the nucleus. A two-tailed
unpaired Student’s t-test was performed to test for signiﬁcance in
all experiments.
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